期刊文献+

全反式维甲酸联合丁酸甘油酯诱导滤泡状甲状腺癌的实验研究 被引量:3

Combination of all-trans retinoic acid with tributyrin induced human follicular thyroid carcinoma
原文传递
导出
摘要 目的探讨全反式维甲酸(ATRA)联合丁酸甘油酯(TB)诱导滤泡状甲状腺癌细胞株FTC-133钠/碘同向转运体(NIS)和甲状腺球蛋白(Tg)表达及其碘的摄取。方法单独使用1μmol/L ATRA或0.1,0.25,0.5,1mmol/LTB和联合使用该2种药物诱导FTC-13348h后,用实时定量PCR反应检测NISmRNA和唯mRNA的表达,蛋白印迹法检测NIS蛋白表达,放射免疫法检测Tg蛋白含量以及检测FTC-133诱导后摄碘变化。结果TB可诱导FTC-133NIS、Tg蛋白及mRNA的表达增高,并呈剂量依赖性。联合1μmol/LArllRA及各浓度,TB后较单独使用1μmol/LA耵认及,TB明显提高了FTC-133NIS、Tg蛋白及mRNA的表达,并且增加了FTC-133对^125Ⅰ的摄取。结论ATRA联合,TB有效增强了FTC-133的摄碘能力,为低分化甲状腺癌的放射性碘治疗提供了一条新的研究途径。 Objective This study was to evaluate the expressions of thyroid specific sodium/iodide symporter (NIS), thyroglobulin (Tg) and radioiodide accumulation, induced by all-trans retinoic acid (ATRA) and (or) tributyrin (TB) in thyroid carcinoma cell line FTC-133. Methods Thyroid carcinoma ceil line FTC-133 was cultured in the presence of 1μmol/L ATRA and (or) 0.1,0.25, 0.5, 1 mmol/L TB respectively. After 48 h, the expressions of NIS mRNA and Tg mRNA were measured by Realtime RT- PCR, the protein of NIS was identified by Western blot and the protein of Tg was quantified by radioimmunoassay. Moreover, the radioactivity in FTC-133 thyroid carcinoma ceil line was measured. Results In FTC-133 thyroid carcinoma cells, TB alone could induce dependent expression of NIS mRNA, Tg mRNA and the proteins levels. When compared with either 1 μmol/L ATRA or TB alone, the combinations of 1 μmol/L ATRA and TB had higher expressions of the thyroid-specific genes mRNA and proteins and the accumulation of ^125I. Conclusions The combination of ATRA with TB might have the highest accumulation of radioiodide in FTC-133 thyroid carcinoma cell line. This method might possibly help in enhancing the radioiodine accumulation in poorly differentiated thyroid carcinoma cell.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2008年第2期88-91,共4页 Chinese Journal of Nuclear Medicine
基金 上海市科委启明星跟踪计划资助项目(02QMB1405)
关键词 甲状腺肿瘤 维甲酸 甘油酯类 碘放射性同位素 Thyroid neoplasms Tretinoin Glycerides Iodine radioisotopes
  • 相关文献

参考文献4

二级参考文献21

  • 1Simon D, Korber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med, 2002, 29: 775-782.
  • 2Sambrook J, Frischauf EF, Mantis T, et al. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.345-347.
  • 3Hansen LA, Sigman CC, Andreola F, et al. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis, 2000, 21: 1271-1279.
  • 4Schmutzler C, Brtko J, Winzer R, et al. Function retinoid and thyroid hoomone receptors in human thyroid cell line and tissues. Int J Cancer1998, 76: 368-376.
  • 5Schmutzler C, Winzer R, Meissner-Weigl J, et al. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun, 1997, 240:832-838.
  • 6Smanik PA, Liu Q, Furminger TL, et al. Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun, 1996, 226: 339-345.
  • 7Lazar- V, Bidart JM, Caillou B, et al. Expression of the Na^+/I^- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab, 1999, 84: 3228-3234.
  • 8Van Herle AJ, Agatep ML, Padua Ⅲ DN, et al. Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells(UCLA RO 82 W-1) in vitro. J Clin Endocrinol Metab, 1990, 71: 755-763.
  • 9Caillou B, Troalen F, Baudin E, et al. Na^+ /I^- symporter distribution in human thyroid tissues: an immunohistochemical study. J Clin Endocrinol Metab, 1998, 83: 4102-4106.
  • 10Castro MR, Bergert ER, Goellner JR, et al. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab, 2001, 86: 5627-5632.

共引文献19

同被引文献43

  • 1张一帆,李彪,赵龙,朱承谟.维甲酸诱导甲状腺癌细胞摄碘的实验研究[J].中华核医学杂志,2005,25(2):90-93. 被引量:5
  • 2Buchsbaum DJ, Chaudhuri TR, Zinn KR. Radiotargeted gene therapy. J Nucl Med, 2005, 46 Suppl: 179s-186s.
  • 3Gambhir SS, Barrio JR, Phelps ME, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA, 1999, 96 : 2333-2338.
  • 4Barzon L, Boscaro M, Palu M. Endocrine aspects of cancer gene therapy. Endocr Rev, 2004, 25 : 1- 44.
  • 5Dai G, Levy O, Carrasco N, et al. Cloning and characterization of the thyroid iodide transporter. Nature, 1996, 379: 458-460.
  • 6Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med, 2002, 43: 1188-1200.
  • 7Schmutzler C, Winzer R, Meissner-Weigl J, et al. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun, 1997, 240: 832-838.
  • 8Dohan O, Vieja A, Paroder A, et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Reviews, 2003, 24: 48-77.
  • 9Niu G, Gaut AW, Ponto LLB, et al. Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. J Nucl Med, 2004, 45: 445-449.
  • 10Willhauck MJ, Samani BR, Gildehaus FJ, et al. Application of lss Re as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. J Clin Endocrin Metab, 2007, 92: 4451-4458.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部